Kapitel in diesem Buch

1. Frontmatter I
2. Preface VII
3. Foreword IX
4. Contents XI
5. List of Tables and Figures XVII
6. PART ONE. Introduction
7. CHAPTER ONE. Introduction 3
8. CHAPTER TWO. The Development of the Retail Drug Industry 9
9. CHAPTER THREE. Government Regulation of the Retail Drug Industry 36
10. CHAPTER FOUR. The Philosophy of Restrictionism 54
11. PART TWO. Restrictions on the Sale of Proprietary Drugs
12. CHAPTER FIVE. Issues Involved in the Sales Restriction Controversy 83
13. CHAPTER SIX. Litigation and Legislation Concerning Sales Restrictions 98
14. PART THREE. Restrictive Pharmacy Laws and the Resulting Litigation
15. CHAPTER SEVEN. Pharmacy Ownership Restrictions 137
16. CHAPTER EIGHT. Recent Pharmacy Ownership Litigation 161
17. CHAPTER NINE. Recent Pharmacy Ownership Litigation: The Superx Case 174
18. CHAPTER TEN. Operating Constraints: General Prohibitions, Physical Requirements, and Advertising Restrictions 204
19. CHAPTER ELEVEN. Operating Constraints: Employees and Nondrugstore Sales 242
20. PART FOUR. Results and Implications of Restrictionism
21. CHAPTER TWELVE. Economic Consequences of Free Market Restrictions 277
22. CHAPTER THIRTEEN. Limitations on Managerial Decisions 296
23. CHAPTER FOURTEN. Concluding Observations and Recommendations 306
24. APPENDIX ONE. Selected Provisions of the State Pharmacy Laws and Selected Rules and Regulations of the State Boards of Pharmacy 319
25. APPENDIX TWO. Physician Ownership Bill Introduced by Senator Hart 416
26. APPENDIX THREE. Revised Physician Ownership Bill Introduced by Senator Hart 421
27. Bibliography 425
28. Index 435